Intelligence Profile
Clinical Applications
Tadalafil is a phosphodiesterase-5 (PDE5) inhibitor primarily used in the treatment of erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and certain cases of pulmonary hypertension. Its clinical applications are supported by various studies and trials:
Erectile Dysfunction (ED):
Tadalafil is highly effective in treating erectile dysfunction. A systematic review and network meta-analysis highlight its efficacy as part of medical interventions for ED after prostate cancer treatment (PMID: 42557727). Clinical trials (e.g., NCT00931528 and NCT07602608) also explore its use in preventing and treating ED, even when supplemented with therapies like platelet-rich plasma.Lower Urinary Tract Symptoms (LUTS) due to BPH:
Tadalafil is used to manage lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS), improving symptoms and quality of life (NCT02431754). It has shown positive effects on endothelial, angiogenic, and metabolic profiles in men with BPH and ED (PMID: 42538422).Pulmonary Hypertension:
Tadalafil targets the NO-sGC-cGMP pathway and has therapeutic efficacy in treating chronic thromboembolic pulmonary hypertension (PMID: 42516671).Prevention of Erectile Dysfunction Post-Treatment:
Clinical trials have investigated its role in preventing ED following radiation therapy in prostate cancer patients (NCT00931528), extending its application beyond immediate symptoms to prophylactic use.Peyronie's Disease:
A review suggests that active Peyronie's disease could be an early treatment window with antifibrotic potential, although further specific implications of tadalafil in this context require more evidence (PMID: 42564900).Duchenne Muscular Dystrophy:
An early-phase trial (NCT01359670) explored tadalafil alongside sildenafil in managing Duchenne Muscular Dystrophy, though its direct clinical benefits in this area are less established.
Additional Considerations:
The risk of glaucoma when using tadalafil for LUTS has been examined, though the implications are still being explored (PMID: 42552102).
Disclaimer: This summary is for informational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider for treatment decisions.